Modern approaches to prevetion and treatment of anemia of prematurity (literature review)
Abstract
Anemia of prematurity occurs in the vast majority of extremely immature newborns or infants with extremely low birth weight. It is known that this pathological condition develops the higher than shorter is baby’s gestational age. However, due to a number of factors, anemia of prematurity may occur in newborns with moderate or mild prematurity. This review summarizes and systematizes modern data on non-drug prevention of anemia of prematurity, which includes delayed umbilical cord clamping, umbilical cord milking, optimization of blood sampling, approaches to enteral and parenteral nutrition of premature infants. We also presented information about drug prevention and results of recent studies of treatment using blood transfusion and erythropoietin preparations.
About the Authors
А. M. Kozarezova
Институт ПК и ПКЗ УО «Белорусский государственный медицинский университет»; Клинический родильный дом Минской области
Belarus
Belarus
N. N. Klimkovich
Институт ПК и ПКЗ УО «Белорусский государственный медицинский университет»
Belarus
Belarus
I. M. Krastsialiova
РНПЦ «Мать и дитя»
Belarus
Belarus
S. A. Berestsen
РНПЦ «Мать и дитя»
Belarus
Belarus
O. N. Pechkurova
РНПЦ «Мать и дитя»
Russian Federation
Russian Federation
References
1. Dallman, P. R. Anemia of prematurity / P. R. Dallman // Ann. Rev. Med. — 1981. — Vol. 32. — P. 143—160.
2. Carroll, P. D. Umbilical cord blood-an untapped resource: strategies to decrease early red blood cell transfusions and improve neonatal outcomes / P. D. Carroll // Clin. Perinatol. — 2015. — Vol. 42, iss. 3. — P. 541—556.
3. Ранняя анемия недоношенных (клинические рекомендации) / Е. Н. Балашова [др.] // Неонатология: новости, мнения, обучение. — 2021. — Т. 9, № 3. — С. 47—61.
4. The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants / H. Kirpalani [et al.] // J. Pediatr. — 2006. — Vol. 149, iss. 3. — P. 301—307.
5. Correlation between maternal and childhood VitB12, folic acid and ferritin levels / F. Zeeshan [et al.] // Pak. J. Med. Sci. — 2017. — Vol. 33, iss. 1. — P. 162—166.
6. A randomized, controlled trial of the effects of adding vitamin B12 and folate to erythropoietin for the treatment of anemia of prematurity / N. Haiden [et al.] // Pediatrics. — 2006. — Vol. 118, iss. 1. — P. 180—188.
7. Обеспеченность фолатами глубоконедоношенных детей в современных условиях выхаживания и вскармливания / В. В. Лазарева [и др.] // Неонатология: новости, мнения, обучение. — 2022. — Т. 10, № 4. — С. 8—16.
8. Vitamin A and E status in very low birth weight infants / S. Kositamongkol [et al.] // J. Perinatol. — 2011. — Vol. 31, iss. 7. — P. 471—476.
9. Circulating RBC volume, measured with biotinylated RBCs, is superior to the Hct to document the hematologic effects of delayed versus immediate umbilical cord clamping in preterm neonates / R. G. Strauss [et al.] // Transfusion. — 2003. — Vol. 43, iss. 8. — P. 1168—1172.
10. Acute physiological effects of packed red blood cell transfusion in preterm infants with different degrees of anaemia / L. K. Fredrickson [et al.] // Arch. Dis. Child. Fetal. Neonatal. Ed. — 2011. — Vol. 96, iss. 4. — P. 249—253.
11. Frey, B. The value of capillary whole blood lactate for blood transfusion requirements in anaemia of prematurity / B. Frey, M. Losa // Intensive Care Med. — 2001. — Vol. 27. — P. 222—227.
12. Bailey, S. M. Splanchnic-cerebral oxygenation ratio as a marker of preterm infant blood transfusion needs / S. M. Bailey, K. D. Hendricks-Munoz, P. Mally // Transfusion. — 2012. — Vol. 52. — P. 252—260.
13. Bell, E. F. Red cell transfusion thresholds for preterm infants: finally some answers / E. F. Bell // Arch. Dis. Child. Fetal. Neonatal. Ed. — 2022. — Vol. 107, iss. 2. — P. 126—130.
14. Effect of high-dose erythropoietin on blood transfusions in extremely low gestational age neonates: post hoc analysis of a randomized clinical trial / S. E. Juul [et al.] // JAMA Pediatr. — 2020. — Vol. 174. — P. 933—943.
15. Holzapfel, L. F. Red Blood Cell Transfusion Thresholds for Anemia of Prematurity / L. F. Holzapfel, M. A. Rysavy, E. F. Bell // Neoreviews. — 2023. — Vol. 24, iss. 6. — P. 370—376.
16. Delayed vs early umbilical cord clamping for preterm infants: a systematic review and metaanalysis / M. Fogarty [et al.] // Amer. J. Obstet. Gynecol. — 2018. — Vol. 218. — P. 1—18.
17. Doyle, J. J. The role of erythropoietin in the anemia of prematurity / J. J. Doyle // Semin. Perinatol. — 1997. — Vol. 21. — P. 20—27.
18. Ohlsson, A. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants [Electronic resource] / A. Ohlsson, S. M. Aher // Cochrane Database Syst. Rev. — 2017. — Mode of access: https://www.cochranelibrary.com. — Date of access: 25.07.2024.
19. Ohlsson, A. Late erythropoiesis-stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants [Electronic resource] / A. Ohlsson, S. M. Aher // Cochrane Database Syst. Rev. — 2019. — Vol. 2, iss. 2. — Mode of access: https://www.cochranelibrary.com. — Date of access: 25.07.2024.
20. Yao, S. L. The effectiveness of interventions to prevent intraventricular haemorrhage in premature infants: A systematic review and network metaanalysis / S. L. Yao, E. Smit, D. Odd // J. Neonatal. Perinatal. Med. — 2023. — Vol. 16, iss. 1. — P. 5—20.
21. McCarthy, E. K. Iron supplementation in preterm and low-birth-weight infants: a systematic review of intervention studies / E. K. McCarthy, E. M. Dempsey, M. E. Kiely // Nutr. Rev. — 2019. — Vol. 77, iss. 12. — P. 865—877.
22. Domellof, M. Meeting the Iron Needs of Low and Very Low Birth Weight Infants / M. Domellof // Ann. Nutr. Metab. — 2017. — Vol. 71, iss. 3. — P. 16—23.
23. Erythrocyte transfusions increased the risk of elevated serum ferritin in very low birthweight infants and were associated with altered longitudinal growth / S. Alm [et al.] // Acta. Paediatr. — 2020. — Vol. 109, iss. 7. — P. 1354—1360.
24. Содержание гемоглобина в ретикулоцитах как маркер дефицита железа у недоношенных новорожденных с очень низкой массой тела при рождении. Простые методы диагностики дефицита железа / Д. Р. Шарафутдинова [и др.] // Вопросы гематологии/онкологии и иммунопатологии в педиатрии. — 2023. — T. 22, № 3. — С. 146—155.
25. Eunice Kennedy Shriver NICHD Neonatal Research Network. Higher or Lower Hemoglobin Transfusion Thresholds for Preterm Infants / H. Kirpalani [et al.] // N. Engl. J. Med. — 2020. — Vol. 383, iss. 27. — P. 2639—2651.
26. ETTNO Investigators. Effects of liberal vs restrictive transfusion thresholds on survival and neurocognitive outcomes in extremely low-birthweight infants: The ETTNO randomized clinical trial / A. R. Franz [et al.] // JAMA. — 2020. — Vol. 324, iss. 6. — P. 560—570.
27. Umbilical cord management for newborns <34 weeks’ gestation: a meta-analysis [Electronic resource] / A. L. Seidler [et al] // Pediatrics. — 2021. — Vol. 147, iss. 3. — Mode of access: https://publications. aap.org. — Date of access: 25.07.2024.
28. Effectiveness and safety of umbilical cord milking in premature infants: A randomized controlled trial [Electronic resource] / Y. M. S. Zhang [et al.] // Medicine. — 2023. — Vol. 102, iss. 47. — Mode of access: https://www.sciencedirect.com. — Date of access: 25.07.2024.
29. A mathematical modeling approach to quantify the role of phlebotomy losses and need for transfusions in neonatal anemia / M. R. Rosebraugh [et al.] // Transfusion. — 2013. — Vol. 53, iss. 6. — P. 1353—1360.
30. Neonatal clinical blood sampling led to major blood loss and was associated with bronchopulmonary dysplasia / W. Hellstrom [et al.] // Acta. Paediatr. — 2020. — Vol. 109, iss. 4. — P. 679—687.
31. Impact of the volume of blood collected by phlebotomy on transfusion requirements in preterm infants with birth weight of less than 1500 g. A quasi-experimental study / P. H. Brener Dik [et al.] // Arch. Argent. Pediatr. — 2020. — Vol. 118, iss. 2. — P. 109—116.
32. Is folic acid supplementation really necessary in preterm infants ≤ 32 weeks of gestation? / M. Y. Oncel [et al.] // J. Pediatr. Gastroenterol. Nutr. — 2014. — Vol. 58, iss. 2. — P. 188—192.
33. Amount of folic acid in different types of nutrition used in the neonatal period / T. Revakova [et al.] // Bratisl. Lek. Listy. — 2015. — Vol. 116. — P. 349—353.
34. Worthington-White, D. A. Premature infants require additional folate and vitamin B-12 to reduce the severity of the anemia of prematurity / D. A. Worthington-White, M. Behnke, S. Gross // Amer. J. Clin. Nutr. — 1994. — Vol. 60, iss. 6. — P. 930—935.
35. Enteral Nutrition in Preterm Infants (2022): a position paper from the ESPGHAN committee on nutrition and invited experts / N. D. Embleton [et al.] // J. Pediatr. Gastroenterol Nutr. — 2023. — Vol. 76, iss. 2. — P. 248—268.
36. Vitamin E in the Preterm Infant: A Forgotten Cause of Hemolytic Anemia / E. Gomez-Pomar [et al.] // Amer. J. Perinatol. — 2018. — Vol. 35, iss. 3. — P. 305—310.
37. Update on Vitamin E and Its Potential Role in Preventing or Treating Bronchopulmonary Dysplasia / C. A. Stone Jr. [et al.] // Neonatology. — 2018. — Vol. 113, iss. 4. — P. 366—378.
38. Pacifici, M. G. Effects of vitamin E in neonates and young infants / M. G. Pacifici // Int. J. Pediatr. — 2016. — Vol. 4, iss. 5. — P. 1745—1757.
39. The effect of individualized iron supplementation on iron status in Dutch preterm infants born between 32 and 35 weeks of gestational age: evaluation of a local guideline / M. Vreugdenhil [et al.] // J. Matern. Fetal. Neonatal. Med. — 2022. — Vol. 35, iss. 26. — P. 10279—10286.
40. Iron deficiency and anemia in iron-fortified formula and human milk-fed preterm infants until 6 months post-term / M. van de Lagemaat [et al.] // Eur. J. Nutr. — 2014. — Vol. 53, iss. 5. — P. 1263—1271.
41. Mills, R. J. Enteral iron supplementation in preterm and low birth weight infants [Electronic resource] / R. J. Mills, M. W. Davies // Cochrane Database Syst Rev. — 2012. — Mode of access: https://www.cochranelibrary.com. — Date of access: 25.07.2024.
42. Early and late Iron supplementation for low birth weight infants: a meta-analysis [Electronic resource] / H. X. Jin [et al.] // Ital. J. Pediatr. — 2015. — Vol. 4, iss. 16. — Mode of access: https://ijponline.biomedcentral.com. — Date of access: 25.07.2024.
43. Garcia, M. G. Effect of recombinant erythropoietin on «late» transfusions in the neonatal intensive care unit: A meta-analysis / M. G. Garcia, A. D. Hutson, R. D. Christensen // J. Perinatol. — 2002. — Vol. 22. — P. 108—111.
44. Early Erythropoietin Administration does not Increase the Risk of Retinopathy in Preterm Infants / H. H. Chou [et al.] // Pediatr. Neonatol. — 2017. — Vol. 58, iss. 1. — P. 48—56.
45. Erythropoietin is not a risk factor for severe retinopathy of prematurity among high risk preterm infants [Electronic resource] / K. C. T. Bui [et al.] // Early Hum. Dev. — 2021. — Vol. 161. — Mode of access: https://www.sciencedirect.com. — Date of access: 25.07.2024.
46. Effect of Early Erythropoietin on Retinopathy of Prematurity: a stratified meta-analysis / H. S. Fischer [et al.] // Neonatology. — 2023. — Vol. 120, iss. 5. — P. 566—576.
47. Doyle, J. J. The role of erythropoietin in the anemia of prematurity / J. J. Doyle // Semin. Perinatol. — 1997. — Vol. 21. — P. 20—27.
48. Ohlsson, A. Early erythropoiesis-stimulating agents in preterm or low birth weight infants [Electronic resource] / A. Ohlsson, S. M. Aher // Cochrane Database Syst. Rev. — 2020. — Mode of access: https://www.cochranelibrary.com. — Date of access: 25.07.2024.
49. Early Postnatal Administration of Erythropoietin and Its Association with Neurodevelopmental Outcomes and Incidence of Intraventricular Hemorrhage and Hypoxic-Ischemic Encephalopathy: A Four-Week Observational Study / O. C. Costescu [et al.] // Pediatr. Rep. — 2024. — Vol. 16, iss. 2. — P. 339—352.
50. PENUT Trial Consortium. A randomized trial of erythropoietin for neuroprotection in preterm infants / S. E. Juul [et al.] // N. Engl. J. Med. — 2020. — Vol. 382, iss. 3. — P. 233—243.
51. Bolte, K. Survey on clinical use and non-use of recombinant human erythropoietin in European neonatal units / K. Bolte, R. F. Maier // J. Perinat. Med. — 2020. — Vol. 48, iss. 7. — P. 744—750.
Review
For citations:
Kozarezova А.M., Klimkovich N.N., Krastsialiova I.M., Berestsen S.A., Pechkurova O.N. Modern approaches to prevetion and treatment of anemia of prematurity (literature review). Healthcare. 2024;(10):37-46. (In Russ.)
Views:
7
Email this article 